CF Industries
CF
$123.27
-3.47%
CF Industries Holdings, Inc. is a leading global producer and distributor of nitrogen products, primarily ammonia, urea, UAN, and ammonium nitrate, which are essential inputs for agricultural fertilizers and industrial applications. The company operates large-scale nitrogen manufacturing complexes in North America and the United Kingdom, and holds a joint venture interest in Trinidad and Tobago, leveraging low-cost U.S. natural gas as its primary feedstock to maintain a cost advantage over European and Asian peers. This structural cost leadership positions CF as one of the world's lowest-cost nitrogen producers, a key differentiator in a commodity industry where price is set by marginal global supply. Currently, investor attention is focused on the company's exceptional margin expansion driven by elevated nitrogen prices following geopolitical supply disruptions, including the Strait of Hormuz blockade that stranded a significant portion of global fertilizer supply. The debate centers on the sustainability of these elevated prices and margins, as well as CF's strategic investments in blue and green ammonia, which could open new long-term markets in clean energy and hydrogen transport.…
CF
CF Industries
$123.27
Investment Opinion: Should I buy CF Today?
Based on the synthesis of analyst consensus, valuation, and growth prospects, CF Industries receives a 'Hold' rating. The core thesis is that the company is a low-cost nitrogen producer benefiting from temporarily elevated prices, but the market has already priced in much of the good news, as evidenced by the average analyst target of $125.25, which is 1.9% below the current price of $127.70. The consensus recommendation of 'Hold' (mean rating 3.05) reinforces this neutral stance, suggesting that while the company is fundamentally sound, the risk/reward is balanced at current levels.
The supporting evidence for a Hold includes the stock's attractive trailing PE of 8.61x and forward PE of 11.95x, which are below the broader market but reflect the cyclical nature of the business. Revenue growth of 19.4% year-over-year in Q1 2026 and a net margin of 20.5% demonstrate operational strength, while the dividend yield of 2.6% and low payout ratio of 22.4% provide income and flexibility. However, the forward PE being higher than the trailing PE signals expected earnings decline, and the PEG ratio of 0.26, while low, is based on growth that may not be sustainable. The company's $1.621 billion in trailing free cash flow is a positive, but the EV/EBITDA of 4.41x suggests the market is valuing it on peak earnings.
The biggest risks that could invalidate this thesis include a sharper-than-expected decline in nitrogen prices due to supply normalization, a global economic slowdown reducing agricultural demand, and the company's inability to sustain its cost advantage if natural gas prices rise. The rating would upgrade to Buy if the stock pulls back to the analyst low target of $98.00, offering a more attractive entry point, or if nitrogen prices show signs of sustained strength beyond current expectations. Conversely, a downgrade to Sell would be warranted if revenue growth turns negative or if margins compress below historical averages, such as gross margin falling below 30%. Relative to its history and peers, CF appears fairly valued, with the market pricing in a cyclical downturn; thus, the stock is not undervalued enough to warrant a Buy at this time.
Sign up to view all
CF 12-Month Price Forecast
The 12-month outlook for CF is balanced, with the base case (55% probability) suggesting the stock trades around $125, close to current levels. The bull case (25%) relies on sustained supply disruptions and successful clean energy investments, while the bear case (20%) hinges on a rapid normalization of nitrogen markets. The company's low-cost advantage and strong cash flow provide downside protection, but the cyclical nature of the industry and the already elevated valuation limit upside. I would upgrade to bullish if nitrogen prices show sustained strength and the forward PE compresses below 10x, and downgrade to bearish if revenue growth turns negative or if the Strait of Hormuz fully reopens, triggering a supply glut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CF Industries's 12-month outlook, with a consensus price target around $125.25 and implied upside of +1.6% versus the current price.
Average Target
$125.25
0 analysts
Implied Upside
+1.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$98 - $196
Analyst target range
The stock is covered by 19 analysts, with a consensus recommendation of 'Hold' (mean rating 3.05 on a scale where 1 is Strong Buy and 5 is Strong Sell). The average target price is $125.25, which implies a downside of approximately 1.9% from the current price of $127.70. This suggests that the consensus view is that the stock is fairly valued at current levels, with limited upside potential. The distribution of ratings likely includes a mix of Buy, Hold, and Sell, but the overall sentiment leans neutral to slightly bearish given the average target below the current price.
Bulls vs Bears: CF Investment Factors
The bull case for CF rests on its structural cost advantage, strong revenue growth, and attractive valuation, while the bear case highlights cyclical risks, limited analyst upside, and the potential for earnings normalization. Currently, the bear evidence appears slightly stronger due to the consensus 'Hold' rating and the forward PE implying an earnings decline, which suggests the market is pricing in a downturn. The most critical tension is the sustainability of elevated nitrogen prices; if they remain high due to persistent supply disruptions, the bull case could prevail, but any normalization would likely lead to a significant de-rating. Investors must weigh the company's low-cost position against the inherent volatility of commodity markets.
Bullish
- Low-Cost Producer Advantage: CF benefits from low-cost U.S. natural gas feedstock, giving it a structural cost advantage over European and Asian nitrogen producers. This is reflected in its Q1 2026 operating margin of 33.4% and net margin of 20.5%, which are robust for a commodity chemical producer.
- Strong Revenue Growth Momentum: Q1 2026 revenue grew 19.4% year-over-year to $1.986 billion, continuing a multi-quarter acceleration from $1.524 billion in Q4 2024. This top-line expansion is driven by elevated nitrogen prices and strong demand, with ammonia and urea contributing $627 million and $590 million respectively.
- Attractive Valuation Metrics: The stock trades at a trailing PE of 8.61x and a forward PE of 11.95x, both below the broader market. The PEG ratio of 0.26 suggests undervaluation relative to expected earnings growth, and the dividend yield of 2.6% with a low payout ratio of 22.4% provides income potential.
- Robust Free Cash Flow and Balance Sheet: CF generated $1.621 billion in trailing free cash flow, supporting shareholder returns and strategic investments. The current ratio of 3.37 indicates strong liquidity, and the debt-to-equity ratio of 0.82 is manageable, with interest coverage comfortably above 10x based on Q1 2026 EBIT of $640 million and interest expense of $39 million.
Bearish
- Analyst Consensus Points to Limited Upside: The average analyst target price is $125.25, implying a 1.9% downside from the current price of $127.70. With a consensus recommendation of 'Hold' (mean rating 3.05), the market appears to believe the stock is fairly valued, and the high target of $195.72 is offset by a low target of $98.00, indicating wide dispersion.
- Forward PE Implies Earnings Decline: The forward PE of 11.95x is higher than the trailing PE of 8.61x, suggesting analysts expect earnings to decline. This is likely due to anticipated normalization of nitrogen prices from elevated levels, which could pressure margins and profitability.
- Cyclical Downturn Risk: CF operates in a highly cyclical commodity industry. The recent margin expansion is driven by geopolitical supply disruptions, including the Strait of Hormuz blockade, which stranded a third of global fertilizer supply. As these disruptions ease, nitrogen prices could fall, compressing margins and earnings.
- Recent Price Pullback and Volatility: The stock has declined 6.1% over the past month and 4.6% on the last trading day, with a max drawdown of 25.75% over the past 180 days. This volatility, combined with a short ratio of 3.4, suggests potential for further downside if momentum reverses.
CF Technical Analysis
CF Industries is in a sustained uptrend, with the stock up 51.84% over the past year and 59.37% year-to-date, significantly outperforming the S&P 500's 15.01% and 11.70% respective gains. The current price of $127.70 sits at approximately 78.5% of the 52-week range, calculated as ($127.70 - $75.42) / ($141.96 - $75.42), indicating the stock is trading in the upper portion of its annual range but not at its peak. This positioning suggests strong momentum but also leaves room for further upside if the uptrend continues, though it also implies vulnerability to profit-taking near resistance. The 52-week low of $75.42 and high of $141.96 frame the trading envelope, with the current price roughly 10% below the high and 69% above the low, reflecting a robust recovery from prior weakness.
Beta
0.40
0.40x market volatility
Max Drawdown
-25.8%
Largest decline past year
52-Week Range
$75-$142
Price range past year
Annual Return
+44.9%
Cumulative gain past year
| Period | CF Return | S&P 500 |
|---|---|---|
| 1m | -4.9% | +1.0% |
| 3m | +20.7% | +5.4% |
| 6m | -3.8% | +17.8% |
| 1y | +44.9% | +16.5% |
| ytd | +53.8% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CF Fundamental Analysis
CF's revenue trajectory has been robust, with Q1 2026 revenue reaching $1.986 billion, up 19.42% year-over-year from $1.663 billion in Q1 2025. This growth is part of a multi-quarter acceleration: revenue rose from $1.524 billion in Q4 2024 to $1.659 billion in Q3 2025, $1.872 billion in Q4 2025, and $1.986 billion in Q1 2026, driven by higher nitrogen prices and strong demand. The segment breakdown for Q1 2026 shows ammonia at $627 million, UAN at $583 million, urea at $590 million, and AN at $69 million, with ammonia and urea being the largest contributors. The consistent top-line expansion underscores CF's ability to capitalize on favorable market conditions, but the sustainability of this growth hinges on global nitrogen pricing and supply dynamics.
Quarterly Revenue
$2.0B
2026-03
Revenue YoY Growth
+19.4%
YoY Comparison
Gross Margin
37.6%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CF Overvalued?
With trailing net income positive at $615 million in Q1 2026, the PE ratio is the primary valuation metric. The trailing PE stands at 8.61x, while the forward PE is 11.95x, implying the market expects earnings to decline, likely due to anticipated normalization of nitrogen prices from current elevated levels. This gap between trailing and forward PE suggests that analysts are pricing in a cyclical downturn in profitability, despite the recent strong results. The forward PE of 11.95x is still relatively low compared to the broader market, but the direction of earnings expectations is a critical consideration for valuation.
PE
8.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks for CF are centered on its exposure to nitrogen price volatility and the potential for margin compression. While the company generated $615 million in net income in Q1 2026, a 19.4% year-over-year revenue increase, and maintains a healthy current ratio of 3.37, its profitability is highly sensitive to selling prices. The debt-to-equity ratio of 0.82 is moderate, but interest expense of $39 million in Q1 2026 consumes a portion of operating income. Additionally, the company's revenue is concentrated in nitrogen products, with ammonia and urea accounting for over 60% of Q1 2026 sales, leaving it vulnerable to demand shocks or price declines in these specific markets. The trailing free cash flow of $1.621 billion provides a cushion, but a sustained downturn in nitrogen prices could rapidly erode cash generation and limit financial flexibility.
Market and competitive risks include the cyclical nature of the fertilizer industry and the potential for new supply to come online, which could pressure prices. CF's beta of 0.399 indicates low correlation with the broader market, but the stock is still subject to sector-specific risks. Recent news highlights the reopening of the Strait of Hormuz, which could restore global fertilizer supply and reduce the geopolitical premium that has boosted prices. The stock's 51.8% one-year gain and 59.4% year-to-date rise have been driven by these supply disruptions; any easing could trigger a sharp reversal. Furthermore, the consensus analyst target of $125.25 implies a 1.9% downside, and the 'Hold' rating suggests limited confidence in further upside. Valuation compression is a real threat, as the forward PE of 11.95x already prices in an earnings decline, and any miss could lead to multiple contraction.
The worst-case scenario for CF would be a combination of rapidly normalizing nitrogen prices, increased global supply, and a broader market downturn. If the Strait of Hormuz remains open and other producers ramp up output, nitrogen prices could fall back to pre-disruption levels, compressing margins and earnings. The 52-week low of $75.42 represents a 40.9% decline from the current price of $127.70, and the analyst low target of $98.00 implies a 23.3% downside. In a severe downturn, the stock could test its 52-week low, resulting in a loss of approximately 41% from current levels. Additionally, the max drawdown over the past 180 days was 25.75%, indicating that sharp corrections are not uncommon. Investors should be prepared for significant volatility and potential capital impairment if the cycle turns.
FAQ
The primary risk is commodity price risk: nitrogen prices are highly volatile and currently elevated due to geopolitical supply disruptions. A reopening of the Strait of Hormuz could restore supply and cause prices to plummet, compressing margins. Second, earnings risk: the forward PE of 11.95x implies analysts expect earnings to decline, and any miss could trigger a sell-off. Third, operational risk: CF's cost advantage depends on low U.S. natural gas prices; a spike would erode margins. Fourth, market risk: the stock has a low beta of 0.399, but it is still subject to sector rotation and broader market downturns. The max drawdown of 25.75% in the past 180 days highlights the potential for sharp losses.
Our 12-month forecast for CF includes three scenarios. The base case (55% probability) targets a range of $115-$135, assuming nitrogen prices normalize gradually and the stock trades around the analyst average of $125.25. The bull case (25%) targets $141.96-$195.72, driven by sustained supply disruptions and successful clean energy projects. The bear case (20%) targets $75.42-$98.00, if supply normalizes rapidly and demand weakens. The most likely scenario is the base case, with the key assumption that CF maintains its cost advantage and earnings decline moderately but remain solid. Investors should watch nitrogen price trends and the Strait of Hormuz situation as key drivers.
CF appears fairly valued based on current metrics. The trailing PE of 8.61x is low, but the forward PE of 11.95x is higher, indicating expected earnings decline. The PEG ratio of 0.26 suggests undervaluation relative to growth, but that growth is likely unsustainable. Compared to peers in the agricultural inputs sector, CF's valuation is in line, and the EV/EBITDA of 4.41x is reasonable for a cyclical producer. The market is pricing in a downturn, as evidenced by the forward PE exceeding the trailing PE. Therefore, the stock is not significantly overvalued, but it also lacks a clear margin of safety, with the analyst average target slightly below the current price.
CF Industries presents a mixed case for investors. On the positive side, the stock trades at a trailing PE of 8.61x and offers a 2.6% dividend yield, with strong free cash flow of $1.621 billion. However, the analyst consensus is 'Hold' with an average target of $125.25, implying a 1.9% downside from the current price of $127.70. The biggest risk is a normalization of nitrogen prices, which could compress earnings and lead to a lower valuation. For value investors with a long-term horizon and tolerance for commodity volatility, CF could be a good buy on pullbacks, especially near the analyst low target of $98.00. But at current levels, the risk/reward is balanced, making it more of a hold than a strong buy.
CF is more suitable for long-term investment than short-term trading. The company operates in a cyclical industry, and its stock can be volatile, with a beta of 0.399 but a max drawdown of 25.75% in six months. The dividend yield of 2.6% and low payout ratio of 22.4% make it attractive for income-focused investors with a long horizon. Short-term traders might capitalize on price swings, but the lack of clear catalysts and the 'Hold' consensus suggest limited near-term upside. A minimum holding period of 2-3 years is recommended to ride out commodity cycles and benefit from potential long-term growth in blue ammonia. Earnings visibility is moderate, with analyst estimates for 2026 EPS of $7.93, but subject to nitrogen price fluctuations.